menu
    • menu

    Company profile for Sumitomo Pharma America

    NEW Drugs in Dev: 42
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Sumitomo Pharma America (SMPA) is committed to accelerating scientific and therapeutic breakthroughs on behalf of patients in critical disease areas across psychiatry & neurology, oncology, urology, women’s health, rare disease, and cell & gene therapies. SMPA was formed through the consolidation of Sumitomo Pharma’s U.S. affiliate companies including Sunovion Pharmaceuticals, Inc., Sumitomo Pharma America Holdings, Inc., ...
    Sumitomo Pharma America (SMPA) is committed to accelerating scientific and therapeutic breakthroughs on behalf of patients in critical disease areas across psychiatry & neurology, oncology, urology, women’s health, rare disease, and cell & gene therapies. SMPA was formed through the consolidation of Sumitomo Pharma’s U.S. affiliate companies including Sunovion Pharmaceuticals, Inc., Sumitomo Pharma America Holdings, Inc., Sumitomo Pharma Oncology, Inc., Sumitovant Biopharma, Inc., Myovant Sciences, Inc., Urovant Sciences, Inc., and Enzyvant Therapeutics, Inc. SMPA is a Sumitomo Pharma company.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Sumitomo Pharma AmericaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    55 Cambridge Parkway Suite 102W Cambridge, MA 02142
    Telephone
    Telephone
    +1 5084816700
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.us.sumitomo-pharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/sumitomo-pharma-america/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/SumitomoPharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sumitomo AUA Data: Vibegron Works in Men 75+ with OAB and BPH
    Sumitomo AUA Data: Vibegron Works in Men 75+ with OAB and BPH

    18 May 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-05-18/new-data-from-sumitomo-pharma-america-at-aua-2026-highlight-efficacy-of-vibegron-in-men-aged-75-and

    PHARMIWEB
    18 May 2026
    Share Share
    Sumitomo Pharma America Unveils Enzomenib And Nuvisertib Data
    Sumitomo Pharma America Unveils Enzomenib And Nuvisertib Data

    08 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sumitomo-pharma-america-presents-new-investigational-data-on-enzomenib-and-nuvisertib-at-the-2025-american-society-of-hematology-annual-meeting-and-exposition-302635221.html

    PR NEWSWIRE
    08 Dec 2025
    Share Share
    Sumitomo Pharma Unveils Promising Data on Leukemia, Myelofibrosis
    Sumitomo Pharma Unveils Promising Data on Leukemia, Myelofibrosis

    06 Nov 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/clinical-trials/sumitomo-pharma-america-unveils-promising-new-leukemia-and-myelofibrosis-data-ahead-of-ash-2025-18161

    INDPHARMAPOST
    06 Nov 2025
    Share Share
    Sumitomo Pharma America To Unveil New Data at ASH Meeting
    Sumitomo Pharma America To Unveil New Data at ASH Meeting

    03 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sumitomo-pharma-america-to-present-new-investigational-data-at-the-2025-american-society-of-hematology-annual-meeting-302602334.html

    PR NEWSWIRE
    03 Nov 2025
    Share Share
    Sumitomo Pharma Presents New Vibegron Data at 2025 AUA Meeting
    Sumitomo Pharma Presents New Vibegron Data at 2025 AUA Meeting

    29 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sumitomo-pharma-america-presents-new-data-on-vibegron-at-the-2025-american-urological-association-annual-meeting-302440736.html

    PR NEWSWIRE
    29 Apr 2025
    Share Share
    Foundation Medicine, Sumitomo Partner On Acute Leukemia Therapy
    Foundation Medicine, Sumitomo Partner On Acute Leukemia Therapy

    18 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250218523943/en

    BUSINESSWIRE
    18 Feb 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search